Stocktoria
Allogene Therapeutics, Inc. ALLO
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2018-10-11
Allogene Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 16,445,682 | $38.3M | 7.17% |
| CITADEL ADVISORS LLC | 10,223,370 | $21.3M | 4.46% |
| TWO SIGMA INVESTMENTS, LP | 7,784,348 | $16.2M | 3.39% |
| MILLENNIUM MANAGEMENT LLC | 4,843,889 | $10.1M | 2.11% |
| D. E. Shaw & Co., Inc. | 4,710,735 | $9.8M | 2.05% |
| RENAISSANCE TECHNOLOGIES LLC | 3,834,312 | $8.0M | 1.67% |
| AQR CAPITAL MANAGEMENT LLC | 2,006,288 | $4.2M | 0.87% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.